Could six months of bupropion double quit rates for african american smokers?
NCT ID NCT05732272
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tests whether taking the quit-smoking drug bupropion for 6 months works better than the usual 7-week course for African American adults who smoke daily. Researchers will enroll 500 participants and check if more people stay smoke-free at 6 months with the longer treatment. The goal is to find a more effective way to help this community quit smoking for good.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
bupropion
What this could lead to
If successful, this could provide a more effective, tailored smoking cessation approach for African American smokers, who often face higher quit barriers.
What could go wrong
This is a Phase 3 trial, but results may not apply to all smokers. Bupropion can cause side effects like insomnia or dry mouth, and some participants may still relapse.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMOKING CESSATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Kansas Medical Center
RECRUITINGKansas City, Missouri, 64130, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••